Under the agreement, bioAffinity’s sputum analysis will be combined with Pictor’s proteomic platform to analyse inflammation.

The tests will help identify the inflammatory pathways involved in patients with COPD and asthma to help better guide therapy selection.

Jul 22, 2026--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted the ...

ARUP Laboratories has launched the clinical CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay for multiple ...

AI flow cytometry analysis has become the default approach for cell population discovery once a panel outgrows what a scientist can gate by eye. Manual gating does not scale to today's high-parameter ...

A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA), led by Peter Lillehoj and Kevin Mchugh, have developed an innovative AI-enabled microfluidic ...

After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...

Flow cytometry remains a critical technology for the high-throughput analysis of single cells in complex populations. Attention to good analysis practices is more important than ever due to the recent ...

With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...

For example, flow cytometry can distinguish different cellular properties from morphology to cell cycle stage. Furthermore, the information provided by a flow cytometer reflects the individual cells ...